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Abstract This paper systematically reviewed randomized
clinical trials (RCT) assessing the efficacy of manual thera-
pies for cervicogenic headache (CEH). A total of seven
RCTs were identified, i.e. one study applied physiother-
apy ± temporomadibular mobilization techniques and six
studies applied cervical spinal manipulative therapy (SMT).
The RCTs suggest that physiotherapy and SMT might be an
effective treatment in the management of CEH, but the
results are difficult to evaluate, since only one study included
a control group that did not receive treatment. Furthermore,
the RCTs mostly included participant with infrequent CEH.
Future challenges regarding CEH are substantial both from a
diagnostic and management point of view.
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Introduction
Cervicogenic headache (CEH) is a secondary headache
characterized by unilateral headache and symptoms and
signs of neck involvement [1–5]. It is often worsened
by neck movement, sustained awkward head position or
external pressure over the upper cervical or occipital region
on the symptomatic side [1, 3].
The prevalence of CEH varies in the general population
depending on the diagnostic criteria, i.e. 1.0 % applying six
positive criteria of the Cervicogenic Headache Interna-
tional Study Group (CHISG) and 4.6 % when only five
criteria were used, while it was 2.5 % applying the Inter-
national Headache Society (IHS) criteria [3, 5–8]. A recent
epidemiological survey found that the prevalence was
0.13 % in men and 0.21 % in women applying three or
more major CHISG criteria [9, 10]. Thus, along with dif-
ferent diagnostic criteria, it is likely that other methodo-
logical differences play a role.
The pathogenesis of CEH may originate from various
anatomic structures in the cervical spine. Convergence of
afferents of the trigeminal and upper three cervical spinal
nerves onto the second-order neurons in the trigemino-
cervical nucleus in the upper cervical spinal cord is likely
to lead to the headache [11, 12]. The craniovertebral
junction is stabilized by joint capsules, tectorial membrane,
transverse and alar ligaments [13]. A proton-weighted
magnetic resonance imaging (MRI) study of people with
CEH, whiplash-associated headache or migraine was ana-
lyzed blinded and identified no significant differences in
the three groups [14]. Furthermore, the site of the CEH was
not correlated with the site of signal intensity changes of
the alar and transverse ligaments. One study suggests that
lower cervical disc prolapse may cause CEH [15], but the
results could not be confirmed as no specific MRI changes
of cervical discs or craniovertebral ligaments were found in
CEH [14]. Muscle tenderness is likely to play a role and is
more pronounced on the pain than the non-pain site, i.e.
pericranial tenderness was recorded according to the ten-
derness score of eight pairs of pericranial muscles and
tendon insertion points, each scored on a four-point scale
A. Chaibi (&)  M. B. Russell
Head and Neck Research Group, Research Centre,
Akershus University Hospital, 1478 Lørenskog, Oslo, Norway
e-mail: aleksander.chaibi@medisin.uio.no
M. B. Russell
Institute of Clinical Medicine, Akershus University Hospital,
University of Oslo, 1474 Nordbyhagen, Norway
123
J Headache Pain (2012) 13:351–359
DOI 10.1007/s10194-012-0436-7
(0–3) at each location, and the tenderness score on the pain
and non-pain sides was compared [10]. However, so far the
pathogenesis and etiology of CEH remain a challenge.
Due to insufficient pharmacological treatment strategies,
medication overuse is frequent and likely secondary to the
pain rather than a confounding factor, as the medication
overuse is of shorter duration than the duration of the CEH
[10]. A 3-year follow-up of people with CEH from the
general population found no improvement [16], while
people from the general population with headache attrib-
uted to chronic rhinosinusitis or medication overuse
headache improved after a short advice [16, 17].
Thus, due to muscle tenderness and possibly not yet
identified local factor in the cervical spine, it might be that
manual therapies can alleviate CEH, along with blockage
of the greater occipital nerve (GON), which is the only
effective pharmacological treatment so far [18, 19]. This
paper systematically review randomized clinical trials
(RCT) assessing the efficacy of manual therapies for CEH.
Methods
The literature search was done on CINHAL, Cochrane,
Medline, Ovid and PubMed. Search words were cervico-
genic headache and chiropractic, manipulative therapy,
massage therapy, osteopathic treatment, physiotherapy or
spinal mobilization. All RCT written in English using either
of the manual therapies on CEH were evaluated. CEH was
preferentially classified according to the criteria of the IHS
from 1988 or its revision from 2004, or according to the
Cervicogenic Headache International Study Group (CHISG)
[1–5]. Table 1 shows the diagnostic criteria for CEH. The
studies had to evaluate at least one CEH outcome measure,
i.e. pain intensity, frequency, or duration. The methodolog-
ical quality of the included RCT studies was assessed by the
first author. Table 2 shows that the evaluation covers study
population, intervention, measurement of effect, data pre-
sentation and analysis and the maximum score is 100 points,
and C50 points is considered to be methodology of good
quality [20–23].
Results
The literature search identified seven RCT on CEH that
met our inclusion criteria. One study applied physiother-
apy ± temporomadibular mobilization techniques and six
studies applied cervical spinal manipulative therapy (SMT)
[24–30]. Four studies were conducted by chiropractors, two
studies by physiotherapists and one by a physician. RCTs
studies on massage therapy, spinal mobilization or osteo-
pathic intervention on CEH were not identified.
Methodological quality of the RCTs
Table 3 shows the methodological score of the included
RCT studies. The score varied from 50 to 81 points.
Randomized controlled trials (RCT)
Table 4 shows details from the seven RCT studies regarding
study population, intervention and results in relation to
headache frequency, duration and intensity, while other
results are presented in the text.
Physiotherapy
The Dutch study was conducted by experienced physio-
therapists with unblinded treatment and outcome measures
[30]. The participants were diagnosed with CEH by a
neurologist according to the criteria of the International
Headache Society (IHS) [5]. Participants were excluded, if
ever received temporomandibular disorder (TMD)/ortho-
dontic treatment or experienced neuropathic head pain. The
primary end point was headache intensity while TMD
complaints (mouth opening, pain and range, deviation,
sounds and pain threshold of anterior temporal muscles)
and neck disability were secondary end points. Both TMD
complaints and neck disability improved statistically sig-
nificantly in the experimental group as compared to con-
ventional physiotherapy group at 3- and 6-month follow-up
(p \ 0.001 in both comparisons).
Cervical spinal manipulative therapy
The Danish study was conducted by a chiropractor with
unblinded treatment and blinded analysis of outcome
measures [24]. The participants were diagnosed by a phy-
sician according to the criteria of the IHS excluding the
radiographic criterion [1]. Participants whom had not pre-
viously received SMT or had conditions contraindicated to
SMT were excluded from the study. The primary end-
points were change in headache intensity, headache dura-
tion and NSAIDs consumption from pre-treatment at
2 weeks to post-treatment at week 6. The consumption of
NSAIDs was significantly reduced from pre-treatment to
post-treatment in the cervical SMT group (p \ 0.0005),
but not in the soft tissue (ST) group, however, the reduc-
tion in consumption of NSAIDs was not statistically sig-
nificantly different in the cervical SMT and ST groups
(p = 0.14).
The 2nd Danish study was based on an extended
study population from the 1st Danish study [24, 25]. The
methodology and end-points were similar, except that the
pre-treatment period was reduced from 2 to 1 week and
the statistical calculation was based on median rather than mean
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change. The consumption of NSAIDs was significantly reduced
from pre-treatment to post-treatment in the cervical SMT
group, but not in the ST group, however, the median
reduction in consumption of NSAIDs was not statistically
significantly different in the cervical SMT and ST groups
(p = 0.14).
The Australian multicenter study was conducted by 25
experienced physiotherapists with unblinded treatment and
blinded outcome measures [26]. The study participants
were diagnosed according to the diagnostic criteria of
CHISG by GPs or physiotherapists [4]. Those with bilat-
eral headache, conditions that contraindicated to spinal
manipulative treatment (SMT) or whom had received
physiotherapy or chiropractic treatment for headache
within the previous year were excluded. The primary end-
point was a change in headache frequency from baseline to
immediately after treatment and 12 months after the
intervention, while headache intensity, duration and neck
pain were secondary end-points. Neck pain was reduced
immediate post-treatment in the all intervention groups
(p \ 0.001–0.01), but was only maintained at 12-month
follow-up in the exercise group and combined SMT and
exercise group (p \ 0.001–0.01). The median medication
intake comparing baseline with 12-month follow-up was
reduced 93 % in the combined SMT and exercise group,
100 % in the SMT and exercise groups, while it increased
33 % in the control (p \ 0.015 for all). The authors suggest
that the treatment effect may be underestimated since 46 %
of controls received active intervention (unspecified) for
their headache within the trial period.
An American study conducted by three experienced
chiropractors evaluated the dose response for chiropractic
care of cervicogenic headache [27]. The participants were
diagnosed according to the IHS criteria except the
radiographic criterion [1]. Participants were excluded if
SMT was contraindicated or if the participants had com-
plicated condition that might have been related to clinical
outcome. The primary end-point was a change in mean
headache intensity from baseline to 4- and 12-week fol-
low-up recorded on 100 points modified Von Korff pain
scale. The headache intensity score is the average of
headache intensity today, worst headache intensity within
the last 4 weeks and average headache intensity within
the last 4 weeks. Headache frequency, disability, and
neck pain were secondary end-points. Although the par-
ticipants were allowed to seek consultations outside the
trial, only few used that opportunity. The main results of
the RCT were that several consultations seem to be
advantageous over few consultations in the treatment of
cervicogenic headache (Table 2). At 4- and 12-week
follow-up headache disability was reduced 44, 50, 76 %
and 14, 52, 55 % in the SMT 1, 3 and 4 times a week
groups, while neck pain was reduced by 31, 50, 55 % and
30, 54, 38 %, respectively. Comparison of the SMT 1
time a week group with SMT 3 and 4 times a week groups
was not statistically significant.
Table 1 Diagnostic criteria of cervicogenic headache
Cervicogenic Headache International Study Group [3]
Major criteriaa 1. Symptoms and signs of neck involvement
a. Precipitation of head pain, similar to the
usually occurring one:
i. By neck movement and/or sustained
awkward head positioning, and/or:
ii. By external pressure over the upper
cervical or occipital region on the
symptomatic side
b. Restriction of range of motion (ROM) in
the neck
c. Ipsilateral neck, shoulder, or arm pain of a
rather vague nonradicular nature or,
occasionally, arm pain of a radicular nature.
2. Confirmatory evidence by diagnostic
anesthetic blockade
3. Unilaterality of the head pain, without side
shift
Head pain
characteristics
4. a. Moderate-severe, non-throbbing, and non-
lancinating pain, usually starting in the neck.
b. Episodes of varying duration
c. Fluctuating, continuous pain
Other characteristics
of some importance
5. a. Only marginal effect or lack of effect of
indomethacin
b. Only marginal effect or lack of effect of
ergotamine and sumatriptan
c. Female sex
d. Not infrequent occurrence of head or
indirect neck trauma by history, usually of
more than only medium trauma
Other features of
lesser importance
6. a. Nausea
b. Phonophobia and photophobia
c. Dizziness
d. Ipsilateral ‘‘blurred vision’’
e. Difficulties swallowing
f. Ipsilateral edema, mostly in the periocular
area
International Classification of Headache Disorders-II [5]
A. Pain, referred from a source in the neck and perceived in one or more
regions of the head and/or face, fulfilling criteria C and D
B. Clinical, laboratory and/or imaging evidence of a disorder or lesion
within the cervical spine or soft tissues of the neck known to be, or
generally accepted as, a valid cause of headache
C. Evidence that the pain can be attributed to the neck disorder or lesion
based on at least one of the following:
i. Demonstration of clinical signs that implicate a source of pain in the
neck
ii. Abolition of headache following diagnostic blockade of a cervical
structure or its nerve supply using placebo- or other adequate controls
D. Pain resolves within 3 months after successful treatment of the
causative disorder or lesion
a It is obligatory that one or more of phenomena 1a-1c are present
J Headache Pain (2012) 13:351–359 353
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The German study was conducted by a physician with
blinded participants and unblended treatment and outcome
measures [28]. The study followed the guidelines of the
IHS with slight modifications, as the diagnosis CEH
according to the criteria can only be given retrospectively
after resolution of the symptoms [5]. Participants were
allowed to have co-occurrence of migraine and/or tension-
type headache. Participants were excluded if ever exposed
to SMT or diagnosed with secondary headaches other than
CEH. Main outcome measures were headache frequency,
duration, intensity, medication consumption and days of
absence from school. No statistical significant change
was observed in the treatment or sham group between
baseline and at 2-month follow-up in relation to medi-
cine consumption or days of absence from school due to
headache.
The 2nd American pilot study was conducted by four
experienced chiropractors while additional chiropractors in
Table 2 Criteria list of methodological quality assessment of randomized controlled trials (RCTs) [22]
1. Study population (30 points)
a) Description of inclusion and exclusion criteria (1 point). Restriction to a homogeneous study population (1 point)
b) Comparability of relevant baseline characteristics: duration of complaint (1 point), value of outcome measures (1 point), age (1 point),
recurrences (1 point), and radiating complaints/associated symptoms (1 point)
c) Description of the randomization procedure (2 points). Randomization procedure which excluded bias, i.e. random numbers table
(2 points)
d) Description of dropouts for each group and their reasons (3 points)
e) Loss to follow-up: less than 20 % loss to follow-up (2 points), OR less than 10 % loss to follow-up (4 points)
f) Sample size: greater than 50 subjects in the smallest group after randomization (6 points), OR greater than 100 subjects in the smallest
group after randomization (12 points)
2. Interventions (30 points)
g) Correct description of the manual intervention (5 points). All interventions described (5 points)
h) Pragmatic study: comparison with an existing treatment modality (5 points)
i) Co-interventions avoided in the design of the study (5 points)
j) Comparison with a placebo control group (5 points)
k) Mention of the experience of the therapist (5 points)
3. Measurement of effect (30 points)
l) Placebo controlled studies: patients blinded (3 points), blinding evaluated and fully successful (2 points) OR Pragmatic studies: patients
fully naive, evaluated and fully successful (3 points), time restriction of no manual treatments for at least 1 year (2 points)
m) Outcome measures: pain assessment (2 points), global measure of improvement (2 points), functional status (2 points), spinal mobility
(2 points), medical consumption (2 points)
n) Each blinded outcome measure mentioned under item M earns 2 points
o) Analysis of post-treatment data (3 points), inclusion of a follow-up period longer than 6 months (2 points)
4. Data presentation and analysis (10 points)
p) Intention-to-treat analysis when loss to follow-up is less than 10 % OR intention-to-treat analysis as well as worst-case analysis for
missing values when loss to follow-up is greater than 10 % (5 points)
q) Corrected presentation of the data: mean or median with a standard deviation or percentiles for continuous variables (5 points)
Table 3 Quality score of the analyzed randomized controlled trials (RCTs) using manual therapies for treatment of CEH
Study A B C D E F G H I J K L M N O P Q Total
Piekartz and Lu¨dtke [30] 2 3 4 3 2 0 10 5 0 0 5 2 6 6 3 0 5 56
Nilsson [24] 2 2 4 3 4 0 10 5 5 0 0 2 4 4 3 0 5 53
Nilsson et al. [25] 2 2 4 3 4 0 10 5 5 0 0 2 4 4 3 0 5 53
Jull et al. [26] 2 5 4 3 4 0 10 5 5 5 5 2 8 8 5 5 5 81
Haas et al. [27] 2 4 4 3 4 0 10 5 0 0 5 2 6 0 3 5 5 58
Borusiak et al. [28] 2 2 4 0 4 0 10 0 5 5 5 2 6 0 0 0 5 50
Haas et al. [29] 2 4 4 3 4 0 10 5 0 5 5 2 6 0 3 5 5 63
The letters correspond with letters from the criteria list (Table 2)
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each clinic served as a backup therapist [29]. The treatment
and outcome measures were unblinded. Participants were
diagnosed according to the IHS excluding the radiographic
criteria using a questionnaire [5]. Participants were exclu-
ded if they could not attend two visits per week for
8 weeks, took prophylactic prescribed medication for
headache, had massage or SMT for their headache within
the last 3 months or had complicated conditions. The pri-
mary end-point was headache intensity while secondary
end-points were headache frequency, disability, neck pain
and use of over the counter medication (OTC). At 24 weeks
mean neck pain and mean neck disability were reduced 28 and
52 % in the SMT group treated once a week, 47 and 52 % in
the SMT group treated twice a week, 29 and 45 % in the light
massage (LM) group treated once a week, and 18 and 20 % in
the LM group treated twice a week. The authors concluded
that only the SMT group treated twice a week had clinical
important effect on mean neck pain and disability. Generally
dose effects tended to be small.
Discussion
Methodological considerations
All seven RCTs studies ascertained the participants
through clinical interviews which is considered to be the
most valid method in establishing a precise headache
diagnosis [31]. All the RCTs included relatively few par-
ticipants except the Australian physiotherapy study [26].
However, due to participants were divided into four groups
each with 48–52 participants, even the Australian study did
not receive points for number of participants in the quality
score (Table 3). The number of investigators in the seven
RCTs varied from 1 to 25. The advantage with one
investigator is elimination of inter-observer variability,
which is likely to be present if there are two or more
investigators. The 25 investigators in the Australian study
might be a challenge in relation to the result [32]. The
Dutch study was flawed by the participants not being
blinded to the intervention, as well as co-intervention was
allowed by the investigator which is a major risk for bias
[30]. All the RCTs were considered to be of at least good
methodological quality, i.e. score C50 (Table 3), with the
Australian study standing out with an excellent 81 points
score of the maximum 100 points.
According to the guidelines of the IHS, an intervention
is recommended to last at least 3 months in chronic
migraine trials [33]. All the RCTs had less than 3-month
intervention, varying from a single treatment to 8-week
treatment. In three of SMT the RCTs allowed non-trial
treatment which can lead to biased results [26, 27, 29].
Two of the RCTs included participants with co-occurrenceT
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of migraine and tension-type headache [28, 29], thus, the
effect observed might not be exclusively due to improve-
ment of the CEH.
Only one of the RCTs included a control group that did
not receive treatment [26]. It is generally accepted that
RCTs including a control group are advantages to prag-
matic RCTs, as the effect in the placebo control group
often is high [23]. True net effect is more accurately cal-
culated when adding a control group. One RCT had had a
successful blinding using SMT or sham treatment, the latter
group was denoted as ‘‘control group’’ by the authors [28].
Future RCTs should include a placebo group, i.e. a group
of participant that do not receive treatment, although, it is
known that blinding adult participants in SMT trials is
difficult [34]. Thus, the lack of control group that do not
receive treatment makes interpretation of the results diffi-
cult, since many of the RCTs had ‘‘control groups’’ that
receive a non SMT treatment that might had some effect.
Results
The Dutch study was considered to be of good methodo-
logical quality, although it had room for many improve-
ments [30]. The experimental group had a statistically
significant improvement in headache intensity as compared
to conventional physiotherapy, an effect that must be
considered to also be of clinical significance as the head-
ache intensity was reduced[50 %. The study stands alone,
since it also included TMD complaints that also improved.
The study included multimodal treatment modalities such
as exercise, and thus the results cannot with certainty be
exclusive of manual intervention.
The two Danish studies were based on the same study
population, with additional 15 participants in the 2nd
Danish study [24, 25]. The 1st Danish study presented
mean data and the 2nd Danish study presented median
data. The median but not mean headache duration and
intensity was statistically significantly reduced in the SMT
group as compared to the ST group [24, 25]. The 59 and
52 % mean reduction of headache duration in the SMT and
ST groups is clinically meaningful, and the 36 and 22 %
mean reduction in headache intensity in the two groups is
also likely to be clinically meaningful.
The Australian study showed a significant reduction in
headache frequency and intensity in all active treatment
groups as compared to the control group, an effect that was
maintained at 12-month follow-up [26].
The 1st American RCT was a dose–response study
without statistical significant results, but there was a ten-
dency toward favouring SMT three or four times a week
for SMT once a week [27]. The study did not avoid co-
intervention in the any of the three groups leading to a
possible bias.
The German RCT included children and adolescent and
had only one treatment session, and found no statistically
significant differences [28]. Due to the single treatment, it
cannot be excluded that more treatment sessions might
have given another result, considering that CEH is known
to be difficult to treat.
The results of the 2nd American study favoured SMT
for light massage (LM), and favouring SMT four times a
week slightly over SMT three times a week [29].
One of the major problems in all the RCTs is the fact
that the majority of participants had intermittent CEH
[24–30]. However, CEH is often characterized by a con-
tinuous headache with an intensity that might fluctuate
rather than being a paroxysmal disorder [10, 14]. The fact
that CEH is often continuous makes sense, assuming that
CEH is caused by local factors in the neck/cervical spine.
Another major problem is the fact that clinical diagnostic
criteria for CEH have not proved to be valid [35].
Although, applying the diagnosis criteria of CHISG not
including a blockage of the greater occipital nerve (GON)
is equally inter-observer reliable as the diagnosis of
migraine and tension-type headache [36]. Thus, the validity
of a GON blockage as a diagnostic criteria can be ques-
tioned. Medication is usually ineffective in CEH. So far
there have not been conducted any RCTs on the effect of
medicine in CEH. Blockage of the GON might be effective in
CEH [10, 18, 19]. However, an operation of the peripheral
course of GON with special attention to the trapezius insertion
had no effect [37].
Conclusion
Current RCTs suggest that physiotherapy and SMT might
be an effective treatment in the management of CEH.
However, the RCTs mostly included participant with infre-
quent CEH. Future challenges regarding CEH are substantial
both from a diagnostic and management point of view.
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